Evaluation of Treatment Efficacy of Tyrosine Kinase Inhibitors in Rare Single EGFR Exon 21 L861Q Mutation: Single Center Experience

OBJECTIVE: Epidermal growth factor receptor mutations are the second most common oncogenic driver event in non-small cell lung cancer. We aimed to compare the first generation erlotinib treatment with the second generation afatinib treatment in patients with non-small cell lung cancer with epidermal...

Descripción completa

Detalles Bibliográficos
Autores principales: Gürsoy, Pınar, Çakar, Burcu, Ön, Sercan, Göker, Erdem, Nart, Deniz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Thoracic Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361298/
https://www.ncbi.nlm.nih.gov/pubmed/35848437
http://dx.doi.org/10.5152/TurkThoracJ.2022.21270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361298/
https://www.ncbi.nlm.nih.gov/pubmed/35848437
http://dx.doi.org/10.5152/TurkThoracJ.2022.21270

Ejemplares similares